Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Algernon Pharmaceuticalsinc (CSE: AGN )

0.0850 +0.0050 (+6.25%)
Streaming Delayed Price Updated: 9:30 AM EST, Nov 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Algernon Pharmaceuticalsinc

< Previous 1 2 3 4 Next >
Hyperhidrosis Treatment Market Projected to Show Strong Growth: Dermira, Revance Therapeutics, Ulthera, TheraVida
Get an extensive Hyperhidrosis Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
Jessie Poole Nominated As 2023 National Trainer For CoolSculpting
Via Press Release Distribution Service
Anti-aging Services Market May See a Big Move : Allergan, Beiersdorf, Cutera
Stay up-to-date with Anti-aging Services Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Tissue Engineering Market Next Big Thing : Major Giants- Allergan, Biotime, B. Braun
Stay up-to-date with Tissue Engineering Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Europe Infusion Therapy Market Is Expected to Grow at a CAGR of 7.2% During the Forecast Period 2023-2030
The Europe Infusion Therapy market size was valued at US$ 11,069.73 million in 2022 and is estimated to reach US$ 19,152.54 million by 2030, growing at a CAGR of 7.2% during the forecast period... 
Via SBWire
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000. 
Via MarketBeat
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
'Wall Street God' Who Made A 100x Return On COVID Market Crash Doesn't Dare Bet Against This Industry
There may not be an investor anywhere who played the March 2020 COVID-induced market crash more deftly than Bill Ackman.  
Via Benzinga
The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News
Via ACCESSWIRE
Irritable Bowel Syndrome Treatment Market 2022 Treatment Analysis, Outlook, Research and SWOT Analysis by Key Players - Allergan Plc, Synergy Pharmaceuticals, Inc, Abbott
A disordered bowel movement in irritable bowel syndrome is characterized by abdominal pain and altered behaviour. It impairs the natural progression of intestinal muscle linings while eating to move... 
Via SBWire
AiViva's Diverse Product Pipeline Could Have The Potential To Transform Unmet Medical Needs
AiViva BioPharma is a clinical-stage biotech company developing innovative and transformative treatments and products to address unmet medical needs for a wide array of diseases.  
Via Benzinga
Lemont Medspa Expands Services And Service Area
Via Get News
Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video
Vancouver, British Columbia--(Newsfile Corp. - November 8, 2022) - Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) – The company is focused on... 
Via Newsfile
Drug Repurposing Market to Eyewitness Huge Growth by 2027 : Allergan, Astellas Pharma, Biovista, NuMedii
Stay up-to-date with Drug Repurposing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures Product Safety
As Sales of Botox and Juvederm Begin to Stall, the Abbvie Stock Price Drops
AbbVie Inc (NYSE:ABBV) AbbVie Inc (NYSE:ABBV) quarterly sales were below Wall Street’s expectations on Friday, primarily due to lower-than-anticipated income from its popular cosmetic filler Juvederm... 
Via PressReach
Topics Economy
Exposures Economy Interest Rates
Eyelashes Enhancing Agents Market to See Major Growth by 2027 : Estee Lauder, Athena, Allergan
How customers and prospects view your existing business and products, benchmark view point to know if it is matching customers’ needs or not. Know possibility and uncover untapped opinions of Eyelashes... 
Via SBWire
Global Botox Market Size to Surpass US$ 8231.4 Million by 2027
Botox Market- The new report offers a powerful combination of the latest, in-depth research studies on the global Botox market. The authors of the report are highly experienced analysts and possess... 
Via SBWire
Global Eye Drops & Lubricants Market Size to Surpass US$ 9824.7 Million by 2027
Eye Drops & Lubricants Market: The authors of the report have deeply researched about key areas of the global Eye Drops & Lubricants market and provided verified market findings and reliable... 
Via SBWire
Dr Ash Labib Recognised for championing the Non-Surgical Rhinoplasty procedure
Via AB Newswire
How Katie Sowden Became The Cosmetic Nurse of Queensland
Via Get News
Autologous Fat Grafting Market Size 2022 : Global Demand Analysis, Growth Status, Strategic Assessment and Feasibility Study by 2028
Autologous Fat Grafting Market 2022-2028 | Major Key Players included in this Report are Sterimedix Ltd , Ranfac Corp , Allergan plc. and Many More with SWOT Analysis by 2028 
Via SBWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
The Power Play by The Market Herald Releases New Interviews with Algernon, Permex Petroleum, Infinity Stone, Green River Gold, HIRE Technologies, and Aton Resources Discussing Their Latest News
Via ACCESSWIRE
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),... 
Via SBWire
The Power Play by The Market Herald Releases New Interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures, ApartmentLove, and Orvana Minerals
VANCOUVER, BC / ACCESSWIRE / July 18, 2022 / The Power Play by The Market Herald has announced the release of new interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures,... 
From The Market Herald
Via AccessWire
The Power Play by The Market Herald Releases New Interviews with K9 Gold, Algernon Pharmaceuticals, Deep-South Resources, and Saturn Oil & Gas
VANCOUVER, BC / ACCESSWIRE / July 7, 2022 / The Power Play by The Market Herald has announced the release of new interviews with K9 Gold, Algernon Pharmaceuticals, Deep-South Resources, and Saturn Oil... 
From The Market Herald
Via AccessWire
Dry Eye Syndrome Treatment Market Size, Share, Key Players Analysis, Growth Factors, New Technology, Application and Regional Forecast to 2028
Global Dry Eye Syndrome Treatment Market Size was estimated at USD 3062.77 million in 2021 and is projected to reach USD 3959.59 million by 2028, exhibiting a CAGR of 3.74% during the forecast period 
Via SBWire
Dystonia Zoo Days Start August 18
In-Person & Virtual Events Connect Dystonia Patients & Support Research toward a CureCHICAGO - July 5, 2022 - PRLog -- The Dystonia Medical Research Foundation (DMRF) is hosting a season of events to... 
Via PRLog
Exposures COVID-19
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.